Global Vero Cell Rabies Vaccines for Human Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Vero Cell Rabies Vaccines for Human market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Vero Cell Rabies Vaccines for Human market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Vero Cell Rabies Vaccines for Human market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Vero Cell Rabies Vaccines for Human market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Vero Cell Rabies Vaccines for Human market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Vero Cell Rabies Vaccines for Human market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Vero Cell Rabies Vaccines for Human
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Vero Cell Rabies Vaccines for Human market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bharat Biotech, Sanofi-Pasteur, Chengda Bio, Prcmise and Zhuoyi Biological, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Vero Cell Rabies Vaccines for Human market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Freeze-dried Powder
Liquid
Market segment by Application
Pre-exposure Prophylaxis
Post-exposure Prophylaxis
Major players covered
Bharat Biotech
Sanofi-Pasteur
Chengda Bio
Prcmise
Zhuoyi Biological
Ningbo Rongan Biological
Indian Immunologicals
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Vero Cell Rabies Vaccines for Human product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Vero Cell Rabies Vaccines for Human, with price, sales, revenue and global market share of Vero Cell Rabies Vaccines for Human from 2018 to 2023.
Chapter 3, the Vero Cell Rabies Vaccines for Human competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Vero Cell Rabies Vaccines for Human breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Vero Cell Rabies Vaccines for Human market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Vero Cell Rabies Vaccines for Human.
Chapter 14 and 15, to describe Vero Cell Rabies Vaccines for Human sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Vero Cell Rabies Vaccines for Human
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Vero Cell Rabies Vaccines for Human Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Freeze-dried Powder
1.3.3 Liquid
1.4 Market Analysis by Application
1.4.1 Overview: Global Vero Cell Rabies Vaccines for Human Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Pre-exposure Prophylaxis
1.4.3 Post-exposure Prophylaxis
1.5 Global Vero Cell Rabies Vaccines for Human Market Size & Forecast
1.5.1 Global Vero Cell Rabies Vaccines for Human Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Vero Cell Rabies Vaccines for Human Sales Quantity (2018-2029)
1.5.3 Global Vero Cell Rabies Vaccines for Human Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Bharat Biotech
2.1.1 Bharat Biotech Details
2.1.2 Bharat Biotech Major Business
2.1.3 Bharat Biotech Vero Cell Rabies Vaccines for Human Product and Services
2.1.4 Bharat Biotech Vero Cell Rabies Vaccines for Human Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Bharat Biotech Recent Developments/Updates
2.2 Sanofi-Pasteur
2.2.1 Sanofi-Pasteur Details
2.2.2 Sanofi-Pasteur Major Business
2.2.3 Sanofi-Pasteur Vero Cell Rabies Vaccines for Human Product and Services
2.2.4 Sanofi-Pasteur Vero Cell Rabies Vaccines for Human Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Sanofi-Pasteur Recent Developments/Updates
2.3 Chengda Bio
2.3.1 Chengda Bio Details
2.3.2 Chengda Bio Major Business
2.3.3 Chengda Bio Vero Cell Rabies Vaccines for Human Product and Services
2.3.4 Chengda Bio Vero Cell Rabies Vaccines for Human Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Chengda Bio Recent Developments/Updates
2.4 Prcmise
2.4.1 Prcmise Details
2.4.2 Prcmise Major Business
2.4.3 Prcmise Vero Cell Rabies Vaccines for Human Product and Services
2.4.4 Prcmise Vero Cell Rabies Vaccines for Human Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Prcmise Recent Developments/Updates
2.5 Zhuoyi Biological
2.5.1 Zhuoyi Biological Details
2.5.2 Zhuoyi Biological Major Business
2.5.3 Zhuoyi Biological Vero Cell Rabies Vaccines for Human Product and Services
2.5.4 Zhuoyi Biological Vero Cell Rabies Vaccines for Human Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Zhuoyi Biological Recent Developments/Updates
2.6 Ningbo Rongan Biological
2.6.1 Ningbo Rongan Biological Details
2.6.2 Ningbo Rongan Biological Major Business
2.6.3 Ningbo Rongan Biological Vero Cell Rabies Vaccines for Human Product and Services
2.6.4 Ningbo Rongan Biological Vero Cell Rabies Vaccines for Human Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Ningbo Rongan Biological Recent Developments/Updates
2.7 Indian Immunologicals
2.7.1 Indian Immunologicals Details
2.7.2 Indian Immunologicals Major Business
2.7.3 Indian Immunologicals Vero Cell Rabies Vaccines for Human Product and Services
2.7.4 Indian Immunologicals Vero Cell Rabies Vaccines for Human Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Indian Immunologicals Recent Developments/Updates
3 Competitive Environment: Vero Cell Rabies Vaccines for Human by Manufacturer
3.1 Global Vero Cell Rabies Vaccines for Human Sales Quantity by Manufacturer (2018-2023)
3.2 Global Vero Cell Rabies Vaccines for Human Revenue by Manufacturer (2018-2023)
3.3 Global Vero Cell Rabies Vaccines for Human Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Vero Cell Rabies Vaccines for Human by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Vero Cell Rabies Vaccines for Human Manufacturer Market Share in 2022
3.4.2 Top 6 Vero Cell Rabies Vaccines for Human Manufacturer Market Share in 2022
3.5 Vero Cell Rabies Vaccines for Human Market: Overall Company Footprint Analysis
3.5.1 Vero Cell Rabies Vaccines for Human Market: Region Footprint
3.5.2 Vero Cell Rabies Vaccines for Human Market: Company Product Type Footprint
3.5.3 Vero Cell Rabies Vaccines for Human Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Vero Cell Rabies Vaccines for Human Market Size by Region
4.1.1 Global Vero Cell Rabies Vaccines for Human Sales Quantity by Region (2018-2029)
4.1.2 Global Vero Cell Rabies Vaccines for Human Consumption Value by Region (2018-2029)
4.1.3 Global Vero Cell Rabies Vaccines for Human Average Price by Region (2018-2029)
4.2 North America Vero Cell Rabies Vaccines for Human Consumption Value (2018-2029)
4.3 Europe Vero Cell Rabies Vaccines for Human Consumption Value (2018-2029)
4.4 Asia-Pacific Vero Cell Rabies Vaccines for Human Consumption Value (2018-2029)
4.5 South America Vero Cell Rabies Vaccines for Human Consumption Value (2018-2029)
4.6 Middle East and Africa Vero Cell Rabies Vaccines for Human Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Vero Cell Rabies Vaccines for Human Sales Quantity by Type (2018-2029)
5.2 Global Vero Cell Rabies Vaccines for Human Consumption Value by Type (2018-2029)
5.3 Global Vero Cell Rabies Vaccines for Human Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Vero Cell Rabies Vaccines for Human Sales Quantity by Application (2018-2029)
6.2 Global Vero Cell Rabies Vaccines for Human Consumption Value by Application (2018-2029)
6.3 Global Vero Cell Rabies Vaccines for Human Average Price by Application (2018-2029)
7 North America
7.1 North America Vero Cell Rabies Vaccines for Human Sales Quantity by Type (2018-2029)
7.2 North America Vero Cell Rabies Vaccines for Human Sales Quantity by Application (2018-2029)
7.3 North America Vero Cell Rabies Vaccines for Human Market Size by Country
7.3.1 North America Vero Cell Rabies Vaccines for Human Sales Quantity by Country (2018-2029)
7.3.2 North America Vero Cell Rabies Vaccines for Human Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Vero Cell Rabies Vaccines for Human Sales Quantity by Type (2018-2029)
8.2 Europe Vero Cell Rabies Vaccines for Human Sales Quantity by Application (2018-2029)
8.3 Europe Vero Cell Rabies Vaccines for Human Market Size by Country
8.3.1 Europe Vero Cell Rabies Vaccines for Human Sales Quantity by Country (2018-2029)
8.3.2 Europe Vero Cell Rabies Vaccines for Human Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Vero Cell Rabies Vaccines for Human Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Vero Cell Rabies Vaccines for Human Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Vero Cell Rabies Vaccines for Human Market Size by Region
9.3.1 Asia-Pacific Vero Cell Rabies Vaccines for Human Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Vero Cell Rabies Vaccines for Human Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Vero Cell Rabies Vaccines for Human Sales Quantity by Type (2018-2029)
10.2 South America Vero Cell Rabies Vaccines for Human Sales Quantity by Application (2018-2029)
10.3 South America Vero Cell Rabies Vaccines for Human Market Size by Country
10.3.1 South America Vero Cell Rabies Vaccines for Human Sales Quantity by Country (2018-2029)
10.3.2 South America Vero Cell Rabies Vaccines for Human Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Vero Cell Rabies Vaccines for Human Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Vero Cell Rabies Vaccines for Human Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Vero Cell Rabies Vaccines for Human Market Size by Country
11.3.1 Middle East & Africa Vero Cell Rabies Vaccines for Human Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Vero Cell Rabies Vaccines for Human Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Vero Cell Rabies Vaccines for Human Market Drivers
12.2 Vero Cell Rabies Vaccines for Human Market Restraints
12.3 Vero Cell Rabies Vaccines for Human Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Vero Cell Rabies Vaccines for Human and Key Manufacturers
13.2 Manufacturing Costs Percentage of Vero Cell Rabies Vaccines for Human
13.3 Vero Cell Rabies Vaccines for Human Production Process
13.4 Vero Cell Rabies Vaccines for Human Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Vero Cell Rabies Vaccines for Human Typical Distributors
14.3 Vero Cell Rabies Vaccines for Human Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Tables and Figures
List of Tables
Table 1. Global Vero Cell Rabies Vaccines for Human Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Vero Cell Rabies Vaccines for Human Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Bharat Biotech Basic Information, Manufacturing Base and Competitors
Table 4. Bharat Biotech Major Business
Table 5. Bharat Biotech Vero Cell Rabies Vaccines for Human Product and Services
Table 6. Bharat Biotech Vero Cell Rabies Vaccines for Human Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Bharat Biotech Recent Developments/Updates
Table 8. Sanofi-Pasteur Basic Information, Manufacturing Base and Competitors
Table 9. Sanofi-Pasteur Major Business
Table 10. Sanofi-Pasteur Vero Cell Rabies Vaccines for Human Product and Services
Table 11. Sanofi-Pasteur Vero Cell Rabies Vaccines for Human Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Sanofi-Pasteur Recent Developments/Updates
Table 13. Chengda Bio Basic Information, Manufacturing Base and Competitors
Table 14. Chengda Bio Major Business
Table 15. Chengda Bio Vero Cell Rabies Vaccines for Human Product and Services
Table 16. Chengda Bio Vero Cell Rabies Vaccines for Human Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Chengda Bio Recent Developments/Updates
Table 18. Prcmise Basic Information, Manufacturing Base and Competitors
Table 19. Prcmise Major Business
Table 20. Prcmise Vero Cell Rabies Vaccines for Human Product and Services
Table 21. Prcmise Vero Cell Rabies Vaccines for Human Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Prcmise Recent Developments/Updates
Table 23. Zhuoyi Biological Basic Information, Manufacturing Base and Competitors
Table 24. Zhuoyi Biological Major Business
Table 25. Zhuoyi Biological Vero Cell Rabies Vaccines for Human Product and Services
Table 26. Zhuoyi Biological Vero Cell Rabies Vaccines for Human Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Zhuoyi Biological Recent Developments/Updates
Table 28. Ningbo Rongan Biological Basic Information, Manufacturing Base and Competitors
Table 29. Ningbo Rongan Biological Major Business
Table 30. Ningbo Rongan Biological Vero Cell Rabies Vaccines for Human Product and Services
Table 31. Ningbo Rongan Biological Vero Cell Rabies Vaccines for Human Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Ningbo Rongan Biological Recent Developments/Updates
Table 33. Indian Immunologicals Basic Information, Manufacturing Base and Competitors
Table 34. Indian Immunologicals Major Business
Table 35. Indian Immunologicals Vero Cell Rabies Vaccines for Human Product and Services
Table 36. Indian Immunologicals Vero Cell Rabies Vaccines for Human Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Indian Immunologicals Recent Developments/Updates
Table 38. Global Vero Cell Rabies Vaccines for Human Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 39. Global Vero Cell Rabies Vaccines for Human Revenue by Manufacturer (2018-2023) & (USD Million)
Table 40. Global Vero Cell Rabies Vaccines for Human Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 41. Market Position of Manufacturers in Vero Cell Rabies Vaccines for Human, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 42. Head Office and Vero Cell Rabies Vaccines for Human Production Site of Key Manufacturer
Table 43. Vero Cell Rabies Vaccines for Human Market: Company Product Type Footprint
Table 44. Vero Cell Rabies Vaccines for Human Market: Company Product Application Footprint
Table 45. Vero Cell Rabies Vaccines for Human New Market Entrants and Barriers to Market Entry
Table 46. Vero Cell Rabies Vaccines for Human Mergers, Acquisition, Agreements, and Collaborations
Table 47. Global Vero Cell Rabies Vaccines for Human Sales Quantity by Region (2018-2023) & (K Units)
Table 48. Global Vero Cell Rabies Vaccines for Human Sales Quantity by Region (2024-2029) & (K Units)
Table 49. Global Vero Cell Rabies Vaccines for Human Consumption Value by Region (2018-2023) & (USD Million)
Table 50. Global Vero Cell Rabies Vaccines for Human Consumption Value by Region (2024-2029) & (USD Million)
Table 51. Global Vero Cell Rabies Vaccines for Human Average Price by Region (2018-2023) & (US$/Unit)
Table 52. Global Vero Cell Rabies Vaccines for Human Average Price by Region (2024-2029) & (US$/Unit)
Table 53. Global Vero Cell Rabies Vaccines for Human Sales Quantity by Type (2018-2023) & (K Units)
Table 54. Global Vero Cell Rabies Vaccines for Human Sales Quantity by Type (2024-2029) & (K Units)
Table 55. Global Vero Cell Rabies Vaccines for Human Consumption Value by Type (2018-2023) & (USD Million)
Table 56. Global Vero Cell Rabies Vaccines for Human Consumption Value by Type (2024-2029) & (USD Million)
Table 57. Global Vero Cell Rabies Vaccines for Human Average Price by Type (2018-2023) & (US$/Unit)
Table 58. Global Vero Cell Rabies Vaccines for Human Average Price by Type (2024-2029) & (US$/Unit)
Table 59. Global Vero Cell Rabies Vaccines for Human Sales Quantity by Application (2018-2023) & (K Units)
Table 60. Global Vero Cell Rabies Vaccines for Human Sales Quantity by Application (2024-2029) & (K Units)
Table 61. Global Vero Cell Rabies Vaccines for Human Consumption Value by Application (2018-2023) & (USD Million)
Table 62. Global Vero Cell Rabies Vaccines for Human Consumption Value by Application (2024-2029) & (USD Million)
Table 63. Global Vero Cell Rabies Vaccines for Human Average Price by Application (2018-2023) & (US$/Unit)
Table 64. Global Vero Cell Rabies Vaccines for Human Average Price by Application (2024-2029) & (US$/Unit)
Table 65. North America Vero Cell Rabies Vaccines for Human Sales Quantity by Type (2018-2023) & (K Units)
Table 66. North America Vero Cell Rabies Vaccines for Human Sales Quantity by Type (2024-2029) & (K Units)
Table 67. North America Vero Cell Rabies Vaccines for Human Sales Quantity by Application (2018-2023) & (K Units)
Table 68. North America Vero Cell Rabies Vaccines for Human Sales Quantity by Application (2024-2029) & (K Units)
Table 69. North America Vero Cell Rabies Vaccines for Human Sales Quantity by Country (2018-2023) & (K Units)
Table 70. North America Vero Cell Rabies Vaccines for Human Sales Quantity by Country (2024-2029) & (K Units)
Table 71. North America Vero Cell Rabies Vaccines for Human Consumption Value by Country (2018-2023) & (USD Million)
Table 72. North America Vero Cell Rabies Vaccines for Human Consumption Value by Country (2024-2029) & (USD Million)
Table 73. Europe Vero Cell Rabies Vaccines for Human Sales Quantity by Type (2018-2023) & (K Units)
Table 74. Europe Vero Cell Rabies Vaccines for Human Sales Quantity by Type (2024-2029) & (K Units)
Table 75. Europe Vero Cell Rabies Vaccines for Human Sales Quantity by Application (2018-2023) & (K Units)
Table 76. Europe Vero Cell Rabies Vaccines for Human Sales Quantity by Application (2024-2029) & (K Units)
Table 77. Europe Vero Cell Rabies Vaccines for Human Sales Quantity by Country (2018-2023) & (K Units)
Table 78. Europe Vero Cell Rabies Vaccines for Human Sales Quantity by Country (2024-2029) & (K Units)
Table 79. Europe Vero Cell Rabies Vaccines for Human Consumption Value by Country (2018-2023) & (USD Million)
Table 80. Europe Vero Cell Rabies Vaccines for Human Consumption Value by Country (2024-2029) & (USD Million)
Table 81. Asia-Pacific Vero Cell Rabies Vaccines for Human Sales Quantity by Type (2018-2023) & (K Units)
Table 82. Asia-Pacific Vero Cell Rabies Vaccines for Human Sales Quantity by Type (2024-2029) & (K Units)
Table 83. Asia-Pacific Vero Cell Rabies Vaccines for Human Sales Quantity by Application (2018-2023) & (K Units)
Table 84. Asia-Pacific Vero Cell Rabies Vaccines for Human Sales Quantity by Application (2024-2029) & (K Units)
Table 85. Asia-Pacific Vero Cell Rabies Vaccines for Human Sales Quantity by Region (2018-2023) & (K Units)
Table 86. Asia-Pacific Vero Cell Rabies Vaccines for Human Sales Quantity by Region (2024-2029) & (K Units)
Table 87. Asia-Pacific Vero Cell Rabies Vaccines for Human Consumption Value by Region (2018-2023) & (USD Million)
Table 88. Asia-Pacific Vero Cell Rabies Vaccines for Human Consumption Value by Region (2024-2029) & (USD Million)
Table 89. South America Vero Cell Rabies Vaccines for Human Sales Quantity by Type (2018-2023) & (K Units)
Table 90. South America Vero Cell Rabies Vaccines for Human Sales Quantity by Type (2024-2029) & (K Units)
Table 91. South America Vero Cell Rabies Vaccines for Human Sales Quantity by Application (2018-2023) & (K Units)
Table 92. South America Vero Cell Rabies Vaccines for Human Sales Quantity by Application (2024-2029) & (K Units)
Table 93. South America Vero Cell Rabies Vaccines for Human Sales Quantity by Country (2018-2023) & (K Units)
Table 94. South America Vero Cell Rabies Vaccines for Human Sales Quantity by Country (2024-2029) & (K Units)
Table 95. South America Vero Cell Rabies Vaccines for Human Consumption Value by Country (2018-2023) & (USD Million)
Table 96. South America Vero Cell Rabies Vaccines for Human Consumption Value by Country (2024-2029) & (USD Million)
Table 97. Middle East & Africa Vero Cell Rabies Vaccines for Human Sales Quantity by Type (2018-2023) & (K Units)
Table 98. Middle East & Africa Vero Cell Rabies Vaccines for Human Sales Quantity by Type (2024-2029) & (K Units)
Table 99. Middle East & Africa Vero Cell Rabies Vaccines for Human Sales Quantity by Application (2018-2023) & (K Units)
Table 100. Middle East & Africa Vero Cell Rabies Vaccines for Human Sales Quantity by Application (2024-2029) & (K Units)
Table 101. Middle East & Africa Vero Cell Rabies Vaccines for Human Sales Quantity by Region (2018-2023) & (K Units)
Table 102. Middle East & Africa Vero Cell Rabies Vaccines for Human Sales Quantity by Region (2024-2029) & (K Units)
Table 103. Middle East & Africa Vero Cell Rabies Vaccines for Human Consumption Value by Region (2018-2023) & (USD Million)
Table 104. Middle East & Africa Vero Cell Rabies Vaccines for Human Consumption Value by Region (2024-2029) & (USD Million)
Table 105. Vero Cell Rabies Vaccines for Human Raw Material
Table 106. Key Manufacturers of Vero Cell Rabies Vaccines for Human Raw Materials
Table 107. Vero Cell Rabies Vaccines for Human Typical Distributors
Table 108. Vero Cell Rabies Vaccines for Human Typical Customers
List of Figures
Figure 1. Vero Cell Rabies Vaccines for Human Picture
Figure 2. Global Vero Cell Rabies Vaccines for Human Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Vero Cell Rabies Vaccines for Human Consumption Value Market Share by Type in 2022
Figure 4. Freeze-dried Powder Examples
Figure 5. Liquid Examples
Figure 6. Global Vero Cell Rabies Vaccines for Human Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Vero Cell Rabies Vaccines for Human Consumption Value Market Share by Application in 2022
Figure 8. Pre-exposure Prophylaxis Examples
Figure 9. Post-exposure Prophylaxis Examples
Figure 10. Global Vero Cell Rabies Vaccines for Human Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Vero Cell Rabies Vaccines for Human Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Vero Cell Rabies Vaccines for Human Sales Quantity (2018-2029) & (K Units)
Figure 13. Global Vero Cell Rabies Vaccines for Human Average Price (2018-2029) & (US$/Unit)
Figure 14. Global Vero Cell Rabies Vaccines for Human Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Vero Cell Rabies Vaccines for Human Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Vero Cell Rabies Vaccines for Human by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Vero Cell Rabies Vaccines for Human Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Vero Cell Rabies Vaccines for Human Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Vero Cell Rabies Vaccines for Human Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Vero Cell Rabies Vaccines for Human Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Vero Cell Rabies Vaccines for Human Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Vero Cell Rabies Vaccines for Human Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Vero Cell Rabies Vaccines for Human Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Vero Cell Rabies Vaccines for Human Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Vero Cell Rabies Vaccines for Human Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Vero Cell Rabies Vaccines for Human Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Vero Cell Rabies Vaccines for Human Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Vero Cell Rabies Vaccines for Human Average Price by Type (2018-2029) & (US$/Unit)
Figure 29. Global Vero Cell Rabies Vaccines for Human Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Vero Cell Rabies Vaccines for Human Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Vero Cell Rabies Vaccines for Human Average Price by Application (2018-2029) & (US$/Unit)
Figure 32. North America Vero Cell Rabies Vaccines for Human Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Vero Cell Rabies Vaccines for Human Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Vero Cell Rabies Vaccines for Human Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Vero Cell Rabies Vaccines for Human Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Vero Cell Rabies Vaccines for Human Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Vero Cell Rabies Vaccines for Human Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Vero Cell Rabies Vaccines for Human Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Vero Cell Rabies Vaccines for Human Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Vero Cell Rabies Vaccines for Human Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Vero Cell Rabies Vaccines for Human Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Vero Cell Rabies Vaccines for Human Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Vero Cell Rabies Vaccines for Human Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Vero Cell Rabies Vaccines for Human Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Vero Cell Rabies Vaccines for Human Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Vero Cell Rabies Vaccines for Human Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Vero Cell Rabies Vaccines for Human Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Vero Cell Rabies Vaccines for Human Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Vero Cell Rabies Vaccines for Human Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Vero Cell Rabies Vaccines for Human Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Vero Cell Rabies Vaccines for Human Consumption Value Market Share by Region (2018-2029)
Figure 52. China Vero Cell Rabies Vaccines for Human Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Vero Cell Rabies Vaccines for Human Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Vero Cell Rabies Vaccines for Human Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Vero Cell Rabies Vaccines for Human Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Vero Cell Rabies Vaccines for Human Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Vero Cell Rabies Vaccines for Human Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Vero Cell Rabies Vaccines for Human Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Vero Cell Rabies Vaccines for Human Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Vero Cell Rabies Vaccines for Human Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Vero Cell Rabies Vaccines for Human Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Vero Cell Rabies Vaccines for Human Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Vero Cell Rabies Vaccines for Human Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Vero Cell Rabies Vaccines for Human Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Vero Cell Rabies Vaccines for Human Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Vero Cell Rabies Vaccines for Human Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Vero Cell Rabies Vaccines for Human Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Vero Cell Rabies Vaccines for Human Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Vero Cell Rabies Vaccines for Human Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Vero Cell Rabies Vaccines for Human Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Vero Cell Rabies Vaccines for Human Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Vero Cell Rabies Vaccines for Human Market Drivers
Figure 73. Vero Cell Rabies Vaccines for Human Market Restraints
Figure 74. Vero Cell Rabies Vaccines for Human Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Vero Cell Rabies Vaccines for Human in 2022
Figure 77. Manufacturing Process Analysis of Vero Cell Rabies Vaccines for Human
Figure 78. Vero Cell Rabies Vaccines for Human Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
Companies Mentioned
Bharat Biotech
Sanofi-Pasteur
Chengda Bio
Prcmise
Zhuoyi Biological
Ningbo Rongan Biological
Indian Immunologicals
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets